SCHEMBL8558374

SCHEMBL8558374

OCc1ccccc1OB(O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 1/20 0.40
EPHX1 P07099 1/20 0.38
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
ENPP2 Q13822 1/20 0.34
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
ORAI1 Q96D31 1/20 0.33
ORAI2 Q96SN7 1/20 0.33
ORAI3 Q9BRQ5 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
LIPE Q05469 1/20 0.32
CYP2A6 P11509 1/20 0.32
TSHR P16473 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30098805 1.00 APOBEC3G (0.40) APOBEC3GEPHX1KDM4EMAPK1SLC6A2
SCHEMBL22635044 0.84 APOBEC3G (0.41) APOBEC3GEPHX1KDM4EMAPK1SLC6A2
SCHEMBL11311567 0.82 APOBEC3G (0.32) APOBEC3GPDCD1CD274
SCHEMBL30366533 0.81 L3MBTL1 (0.48) KDM4EENPP2ORAI1ORAI2ORAI3
SCHEMBL9014978 0.81 ENPP2 (0.33) ENPP2ORAI1ORAI2ORAI3LIPE
SCHEMBL28092250 0.81 PNMT (0.40) KDM4EENPP2ORAI1ORAI2ORAI3
SCHEMBL2126532 0.81 L3MBTL1 (0.48) KDM4EENPP2ORAI1ORAI2ORAI3
SCHEMBL30738550 0.81 ENPP2 (0.33) ENPP2ORAI1ORAI2ORAI3LIPE
SCHEMBL6678412 0.78 ENPP2 (0.44) ENPP2ORAI1ORAI2ORAI3LIPE
SCHEMBL29706601 0.78 ENPP2 (0.44) ENPP2ORAI1ORAI2ORAI3LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119824421-A Molybdenum etching solution 湖北兴福电子材料股份有限公司 2025-04-15 CN claimed
CN-119639127-A Weather-resistant color master batch and preparation method thereof 深圳市金志成塑胶科技有限公司 2025-03-18 CN claimed
CN-118772131-A Biaryl compound and preparation method and application thereof 河南大学 2024-10-15 CN claimed
US-5811559-A Preparation of hydroxybenzaldehyes RHONE-POULENC CHIMIE 1998-09-22 US claimed
CN-119824421-A Molybdenum etching solution 湖北兴福电子材料股份有限公司 2025-04-15 CN disclosed
CN-119639127-A Weather-resistant color master batch and preparation method thereof 深圳市金志成塑胶科技有限公司 2025-03-18 CN disclosed
CN-118772131-A Biaryl compound and preparation method and application thereof 河南大学 2024-10-15 CN disclosed
CN-115403898-B Phenolic resin suitable for RTM process and preparation method and application thereof 西安交通大学 2023-12-19 CN disclosed
CN-116715831-A Borate polyurethane, preparation method thereof, renewable polyurethane material containing borate polyurethane and application of borate polyurethane 安徽足迹新材料科技有限公司 2023-09-08 CN disclosed
CN-116478366-A Fluorescent polyurethane material and preparation method and application thereof 西安交通大学 2023-07-25 CN disclosed
CN-114848657-B Boric acid ester chemosensitizer with symmetrical structure, and preparation method and application thereof 安庆师范大学 2023-04-25 CN disclosed
US-11434420-B2 Color conversion composition, compound used for same, and light emitting device FUJIFILM CORPORATION (JP) 2022-09-06 US disclosed
CN-101863913-B Preparation method of fluorinated aryl-containing boron compound SHANGHAI RES INST CHEMICAL IND 2013-02-27 CN disclosed
CN-102762576-A Benzoxazepine PI3K inhibitor compounds and methods of use HOFFMANN LA ROCHE 2012-10-31 CN disclosed
CN-102083429-A Ido inhibitors NEWLINK GENETICS 2011-06-01 CN disclosed
CN-101863913-A Preparation method of fluorinated aryl-containing boron compound SHANGHAI RES INST CHEMICAL IND 2010-10-20 CN disclosed
CN-101821246-A Tetrazole-substituted arylamide derivatives and uses thereof HOFFMANN LA ROCHE 2010-09-01 CN disclosed
CN-1852712-B Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE 2010-06-09 CN disclosed
CN-1852712-A Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE (CH) 2006-10-25 CN disclosed
US-4291178-A BORATING, HYDROXYMETHYLATION RHONE-POULENC INDUSTRIES (FR) 1981-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434420-B2 Color conversion composition, compound used for same, and light emitting device CRY1, CRY2, CYBA APOBEC3G 229/4885EPHX1 923/4885KDM4E 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.